Wednesday, September 24, 2025 – Friday, September 26, 2025
- Presentation ECTRIMS 2025 – Efficacy and Safety of Vidofludimus Calcium in Progressive Multiple Sclerosis Phase 2 CALLIPER
- Poster ECTRIMS 2025 – Efficacy and Safety of Vidofludimus Calcium in Primary Progressive Multiple Sclerosis Phase 2 CALLIPER
- Poster ECTRIMS 2025 – 144 Week Analysis Confirmed Disability Worsening Events Phase 2 EMPhASIS
- Poster ECTRIMS 2025 – Update Assessment Long-Term Safety and Tolerability Vidofludimus Calcium Phase 2 EMPhASIS
- Poster ECTRIMS 2025 – Potential Neuroprotective Activity by Vidofludimus Calcium in In Vivo Models